Approval · Notice of Compliance 7640 · 2005
MABCAMPATH: Notice of Compliance 7640
Issued November 30, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7640
- Date
- November 30, 2005
- Company
- Genzyme CorporationCambridge, Massachusetts, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MABCAMPATH | 02273993 | Cancelled Post Market |
Medicinal ingredients
- ALEMTUZUMAB 10 MG per ML